Individuals carrying the pE40K variant of ANGPTL4 have lower triglyceride levels, higher high-density lipoprotein (HDL) cholesterol [55], and a reduced risk of coronary artery disease [56]. The gene discussed is ANGPTL4; the disease is coronary artery disorder.